ASTRAZENECA PHARMA INDIA LTD. - Astrazeneca Pharma India Limited Has Received An Import And Market Permission In Form CT-20 (Subsequent New Drug Approval) From The Central Drugs Standard Control Organisation, Directorate General Of Health Services, Government Of India For Dapagliflozin (Forxiga??) Tablets Of 10 Mg

ASTRAZENECA PHARMA INDIA LTD. - Astrazeneca Pharma India Limited Has Received An Import And Market Permission In Form CT-20 (Subsequent New Drug Approval) From The Central Drugs Standard Control Organisation, Directorate General Of Health Services, Government Of India For Dapagliflozin (Forxiga??) Tablets Of 10 Mg - Additional/ Extended Indication

Download	< Back
25 Nov 2022
Please find the enclosed letter of the Company in relation to the captioned subject for your reference.
View all announcements for ASTRAZENECA PHARMA INDIA LTD.	Source: BSE India

Stocks	Mutual Funds		Investment tracking
A-Z Gainers - Daily \| Weekly \| Monthly Losers - Daily \| Weekly \| Monthly Group-wise listing IPO \| Top IPOs Recent IPOs \| IPO News Similar Price band Most traded - By volumes Top 100 - By market capitalisation Latest Company Results Management Speaks Market News	Top 25 schemes High-risk, High-returns Medium-risk, Medium-returns Low-risk, Low-returns Gilt Funds Funds of Funds Special Funds Liquid Funds Dynamic Asset Allocation NFOs MF Selector	Equity - ELSS Equity - Index Funds Equity - Sector Funds Equity - Balance Fund Equity - Diversified Fund MF News Budget 2024	My Portfolio My Watch List If You Had Invested... Global Indicators Forex Converter Market Indices Sectoral Indices World Indices Market Astrology Advertise with us

Stocks

Mutual Funds

Investment tracking